Protein disulfide-isomerase mediates delivery of nitric oxide redox derivatives into platelets

被引:34
作者
Bell, Susannah E. [1 ]
Shah, Chirag M. [1 ]
Gordge, Michael P. [1 ]
机构
[1] Univ Westminster, Dept Biomed Sci, London W1W 6UW, England
关键词
L-amino acid transporter (L-AT); Angeli's salt; diethylamine NONOate (DEANO); glutathione peroxidase (GPx); protein disulphide-isomerase (PDI); S-nitrosoglutathione (GSNO);
D O I
10.1042/BJ20061146
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
S-nitrosothiol compounds are important mediators of NO signalling and can give rise to various redox derivatives of NO: nitrosonium cation (NO+), nitroxyl anion (NO-) and NO center dot radical. Several enzymes and transporters have been implicated in the intracellular delivery of NO from S-nitrosothiols. In the present study we have investigated the role of GPx (glutathione peroxidase), the L-AT (L-amino acid transporter) system and PDI (protein disulfide-isomerase) in the delivery of NO redox derivatives into human platelets. Washed human platelets were treated with inhibitors of GPx, L-AT and PDI prior to exposure to donors of NO redox derivatives (S-nitrosoglutathione, Angeli's salt and diethylamine NONOate). Rapid delivery of NO-related signalling into platelets was monitored by cGMP accumulation and DAF-FM (4-amino-5-methylamino-2'7'-difluorofluorescein) fluorescence. All NO redox donors produced both a cGMP response and DAF-FM fluorescence in target platelets. NO delivery was blocked by inhibition of PDI in a dose-dependent manner. In contrast, inhibition of GPx and L-AT had only a minimal effect on NO-related signalling. PDI activity is therefore required for the rapid delivery into platelets of NO-related signals from donors of all NO redox derivatives. GPx and the L-AT system appeared to be unimportant in rapid NO signalling by the compounds used in the present study. This does not, however, exclude a possible role during exposure of cells to other S-nitrosothiol compounds, such as S-nitrosocysteine. These results further highlight the importance of PDI in mediating the action of a wide range of NO-related signals.
引用
收藏
页码:283 / 288
页数:6
相关论文
共 35 条
[1]   On the specificity of 4-amino-5-methylamino-2′,7′-difluorofluorescein as a probe for nitric oxide [J].
Balcerczyk, A ;
Soszynski, M ;
Bartosz, G .
FREE RADICAL BIOLOGY AND MEDICINE, 2005, 39 (03) :327-335
[2]   Effect of nitroxyl on human platelets function [J].
Bermejo, E ;
Sáenz, DA ;
Alberto, F ;
Rosenstein, RE ;
Bari, SE ;
Lazzari, MA .
THROMBOSIS AND HAEMOSTASIS, 2005, 94 (03) :578-584
[3]  
DEBELDER AJ, 1994, CARDIOVASC RES, V28, P691
[4]   Nitric oxide (NO center dot), the only nitrogen monoxide redox form capable of activating soluble guanylyl cyclase [J].
Dierks, EA ;
Burstyn, JN .
BIOCHEMICAL PHARMACOLOGY, 1996, 51 (12) :1593-1600
[5]   Ingress and reactive chemistry of nitroxyl-derived species within human cells [J].
Espey, MG ;
Miranda, KM ;
Thomas, DD ;
Wink, DA .
FREE RADICAL BIOLOGY AND MEDICINE, 2002, 33 (06) :827-834
[6]   Protein disulfide isomerase and sulfhydryl-dependent pathways in platelet activation [J].
Essex, DW ;
Li, MR ;
Miller, A ;
Feinman, RD .
BIOCHEMISTRY, 2001, 40 (20) :6070-6075
[7]   Decreased platelet inhibition by nitric oxide in two brothers with a history of arterial thrombosis [J].
Freedman, JE ;
Loscalzo, J ;
Benoit, SE ;
Valeri, CR ;
Barnard, MR ;
Michelson, AD .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (04) :979-987
[8]   GLUTATHIONE-PEROXIDASE POTENTIATES THE INHIBITION OF PLATELET-FUNCTION BY S-NITROSOTHIOLS [J].
FREEDMAN, JE ;
FREI, B ;
WELCH, GN ;
LOSCALZO, J .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (01) :394-400
[9]   COPPER CHELATION-INDUCED REDUCTION OF THE BIOLOGICAL-ACTIVITY OF S-NITROSOTHIOLS [J].
GORDGE, MP ;
MEYER, DJ ;
HOTHERSALL, J ;
NEILD, GH ;
PAYNE, NN ;
NORONHADUTRA, A .
BRITISH JOURNAL OF PHARMACOLOGY, 1995, 114 (05) :1083-1089
[10]   Evidence for a cyclic GMP-independent mechanism in the anti-platelet action of S-nitrosoglutathione [J].
Gordge, MP ;
Hothersall, JS ;
Noronha-Dutra, AA .
BRITISH JOURNAL OF PHARMACOLOGY, 1998, 124 (01) :141-148